Ecs Botanics Holdings Ltd has released a press release.
ECS Secures Additional Growth Funding
Filed with ASX ·
6ix hasn’t read this filing yet.
Ecs Botanics Holdings Ltd on 6ix
Earlier from Ecs Botanics
- ECS Half Year FY25 Results
- ECS Achieves 50% Yield Increase with New PCEs
- ECS loan increase by NAB and VESIsorb launch
- Business to Consumer Commercial Update
- Notice of Annual General Meeting/Proxy Form
Later from Ecs Botanics
- Quarterly Activities/Appendix 4C Cash Flow Report (amended)
- Record Harvest and Expansion of Premium B2C Product Line
- Terphogz Launch
- ECS to support UWA medicinal cannabis clinical trial
- Appendix 4E & Annual Report
Follow Ecs Botanics into a list and get an email when it puts out news.
Follow Ecs Botanics